Skip to main content

E Fund Management Co., Ltd.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1842296 GUANGZHOU, F4

Position in REGN

as of Mar 31, 2026 · filed Apr 13, 2026
Position Value
$3,727,988
+$930,263 QoQ
Shares Held
4,825
-9.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

E Fund Management Co., Ltd. holds $77,672,385 across 116 Biotechnology names. REGN ranks #5 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,825 $3,727,988

All Filings in REGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,727,988 4,825
2025-06-30 $2,797,725 5,329
2025-03-31 $3,115,337 4,912
2024-12-31 $2,278,031 3,198
2024-09-30 $2,385,263 2,269
2024-06-30 $2,458,359 2,339
2024-03-31 $1,629,495 1,693
2023-12-31 $1,590,583 1,811
2023-09-30 $1,508,485 1,833
2023-06-30 $1,235,888 1,720
2023-03-31 $1,483,114 1,805
2022-12-31 $1,394,640 1,933
2022-09-30 $1,470,048 2,134
2022-06-30 $1,290,436 2,183
2022-03-31 $1,262,743 1,808
2021-12-31 $1,052,743 1,667
2021-09-30 $1,005,809 1,662
2021-03-31 $821,371 1,736